Rising Health Consciousness Across the Globe Drives Continuous Glucose Monitoring Systems Market to US$ 3.0 Bn in 2032, Future Market Insights

NEWARK, Del, Oct. 07, 2022 (GLOBE NEWSWIRE) — The global continuous glucose monitoring systems market is predicted to reach a value of US$ 3.0 Bn by 2032, with sales growing at a robust CAGR of 10.8% from 2022 to 2032. Scaling up from an estimated US$ 1.1 Bn in 2022, the demand for the target market is expected to be propelled by increasing incidences of diabetes and other related medical conditions. Lifestyle diseases like obesity also lead to diabetes which, in turn, drives the market growth for continuous glucose monitoring systems market during the forecast period. 

Rising incidences of diabetes has become a common occurrence all over the world. In the past two decades, the condition has emerged as a serious health issue. As per WHO, that diabetes-related mortality rates by age has increased by 3% between 2000 and 2019.

The growing awareness about the severity of the illness has led more and more people to begin monitoring their blood glucose level on a regular basis. In addition to this, the increasing health consciousness of people worldwide has resulted in constant glucose monitoring. These considerations has resulted in soaring demand for continuous glucose monitoring systems in the global market space.

Request A Sample PDF: https://www.futuremarketinsights.com/reports/sample/rep-gb-694

Continuous glucose monitoring systems has arisen as a strong player for diabetes management and works effectively just by inserting a bio sensor that transmits the data of glucose levels to the receiver/monitor. Consequently, the primary goal of several glucose monitoring device manufacturers is the development of novel and technologically evolved CGM. This, too, has bolstered the growth of the continuous glucose monitoring systems market.

The constant progress in technology on continuous blood glucose monitoring systems ensure easy, round-the-clock monitoring of the glucose levels for diabetic as well as health conscious people. These devices also display glucose direction and other additional information on monitors, empowering the users with vital information to further assist with diabetes management.

This has led to many collaborations between endocrinologists, credentialed diabetes educators, and stakeholder organisations for diabetes prevention in established as well as emerging markets. Again, a rising geriatric population that suffers from diabetes also supplements the overall growth of the continuous glucose monitoring systems market during the projected period.

“Increasing cases of insulin dependent diabetes will propel the global growth of the continuous glucose monitoring systems market over the forecast period,” says an FMI analyst.  

Key Takeaways:

• High cost of the device will likely hamper the market prospects of continuous glucose monitoring systems.
• The continuous glucose monitoring systems market in China will hold 11.2% of the global market share.
• India’s continuous glucose monitoring systems market will account for 6.7% of the total market share.
• Accounting for 48.5% in 2021, the sensor component segment is slated to grow at 9.4% CAGR during the assessment period.
• By end-user, home care diagnostics will dominate the market with a 9.6% CAGR.

Use Promo Code ->> “FMITODAY” to Get Flat 20% Discount

Competitive Landscape 

Herbalife Nutrition, GNC Holdings, NOW Health, Nutramax Laboratories, Nature’s Bounty, Banyan Botanicals, Source Naturals, Nutramarks Inc, Nature’s Way Products, Abbott, Natural Immunogenics, Solaray Inc., Sambucol USA, Quantum Health, Inc., Vitabiotics Ltd., Rainbow Light, AdvoCare, Pure Encapsulations, LLC., Country Life, LLC, and Natural Health Concept among others are some of the major players in the continuous glucose monitoring systems market profiled in the full version of the report.

Leading market players are focusing on product development and launches to meet the growing demand. These businesses are adopting tactics like mergers, acquisitions, partnerships, and collaborations to expand their consumer base.

More Insights into Continuous Glucose Monitoring Systems Market Report

In its latest report, FMI offers an unbiased analysis of the global continuous glucose monitoring systems market, providing historical data from 2015 to 2021 and forecast statistics for 2022 to 2032.

To understand the global market potential, growth, and scope, the market is segmented on the basis of components (transmitters and monitors, sensors, insulin pump), end user (home care diagnostics, hospitals, ICU/ critical care), and region.

According to the latest FMI reports, based on segmentation, the sensor component segment is expected to register a prolific 9.4% CAGR due to their use of advanced technology and user-friendliness. In terms of end-user, the home care diagnostics category will observe a surge in demand and grow at a stellar 9.6% CAGR during the assessment period. 

Based on region, China and India in the Asia Pacific region are predicted to exhibit impressive growth in the continuous glucose monitoring systems market. China is expected to account for 11.2% of the global market share owing to a rise in insulin-dependent patients which, in turn, has led to many market players increasing their investment in this country.

India’s continuous glucose monitoring systems market will account for 6.7% of the global market share. Rising diabetic population coupled with economic growth will lead to more lucrative opportunities for the market in this country during 2022-2032. Apart from China and India, the United States will also experience substantial market growth during the forecast period.

Access Full Report: https://www.futuremarketinsights.com/reports/continuous-glucose-monitoring-systems-market

Key Market Segments Covered in Continuous Glucose Monitoring Systems Industry Research

By Components:

• Transmitters and Monitors
• Sensors
• Insulin Pump

By End Users:

• Home Care Diagnostics
• Hospitals
• ICU/Critical Care

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa (MEA)

Talk with our expert: https://www.futuremarketinsights.com/ask-question/rep-gb-694

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Components Innovation / Development Trends

4. Key Success Factors

    4.1. Product Adoption, by Region

    4.2. Product Features/ USP’s Analysis

    4.3. Regulatory Landscape

    4.4. Key Promotional Strategies

    4.5. PESTEL Analysis

    4.6. Porter’s Analysis

Explore wide-ranging Coverage of FMI’s Healthcare Market Insights Landscape:

Glucose Sensor Market: The global sales of glucose sensors are projected to grow at a robust CAGR of  8.6%  between 2022 and 2032, totaling around US$ 16,382 Million by the end of 2032.

RFID Blood Monitoring Systems Market: The RFID blood monitoring systems market is anticipated to document a CAGR of 6.9% during the period of 2022-2032. The market is anticipated to reach US$ 218.4 Million in 2032, from US$ 112.0 Million in 2022.

Epilepsy Monitoring Devices Market: The global Epilepsy Monitoring Devices Market is anticipated to grow at a 5% CAGR, reaching US$ 615 Mn by 2026, during the forecast period.

Vital Signs Monitoring Devices Market: Global Vital Signs Monitoring Devices Market is set to experience a significant growth of 8.4% CAGR from 2022 to 2030, with an estimated market value of around US$ 6.8 Bn as of 2022.

Critical Care Patient Monitoring Products Market: The critical care patient monitoring products market is expected to grow at a CAGR of 8.6% during 2022-2032

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Contact Us:

Future Market Insights Inc. 
Christiana Corporate, 200 Continental Drive, 
Suite 401, Newark, Delaware – 19713, USA 
T: +1-845-579-5705 
For Sales Enquiries: [email protected]

Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow